Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis - PubMed (original) (raw)
Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis
B Bonetti et al. Ann Neurol. 1997 Jul.
Abstract
To investigate whether apoptosis is involved in the fate of oligodendrocytes in chronic multiple sclerosis lesions, the pro-apoptotic molecules fas and tumor necrosis factor receptors and the anti-apoptotic molecule bcl-2 were examined by immunohistochemistry, and DNA fragmentation was assessed by an end labeling technique. Fas and both tumor necrosis factor receptors were preferentially expressed on oligodendrocytes in multiple sclerosis lesions, this phenotype being more evident at the lesion edge. The ligand for fasL, was constitutively present at high levels on microglia. The anti-apoptotic molecule bcl-2 was selectively expressed on oligodendrocytes in silent lesions and on astrocytes in active lesions. These molecules were also detected in control material, albeit at lower levels. In chronic active lesions, a few inflammatory cells displayed fas reactivity, whereas the majority expressed bcl-2. DNA fragmentation was found in a number of infiltrating cells and some microglia, whereas, with one possible exception, oligodendrocytes showed no evidence of apoptosis. Thus, while apoptosis is involved in the elimination of infiltrating cells, it plays little or no role in oligodendrocyte depletion in multiple sclerosis, a process that may be related to a lytic pathway. In addition, microglia constitutively displayed the ligand for fas, and appeared to be the major effector cell population in the central nervous system.
Similar articles
- Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque.
Raine CS, Bonetti B, Cannella B. Raine CS, et al. Rev Neurol (Paris). 1998 Sep;154(8-9):577-85. Rev Neurol (Paris). 1998. PMID: 9809372 Clinical Trial. - Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis.
Bonetti B, Pohl J, Gao YL, Raine CS. Bonetti B, et al. J Immunol. 1997 Dec 1;159(11):5733-41. J Immunol. 1997. PMID: 9548518 - Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
Kuhlmann T, Lucchinetti C, Zettl UK, Bitsch A, Lassmann H, Brück W. Kuhlmann T, et al. Glia. 1999 Oct;28(1):34-9. Glia. 1999. PMID: 10498820 - Messengers of cell death: apoptotic signaling in health and disease.
Rossi D, Gaidano G. Rossi D, et al. Haematologica. 2003 Feb;88(2):212-8. Haematologica. 2003. PMID: 12604411 Review.
Cited by
- Discovery of a brain penetrant small molecule antagonist targeting LPA1 receptors to reduce neuroinflammation and promote remyelination in multiple sclerosis.
Poon MM, Lorrain KI, Stebbins KJ, Edu GC, Broadhead AR, Lorenzana AO, Paulson BE, Baccei CS, Roppe JR, Schrader TO, Valdez LJ, Xiong Y, Chen AC, Lorrain DS. Poon MM, et al. Sci Rep. 2024 May 8;14(1):10573. doi: 10.1038/s41598-024-61369-9. Sci Rep. 2024. PMID: 38719983 Free PMC article. - Oligodendrocytes in central nervous system diseases: the effect of cytokine regulation.
Zhang C, Qiu M, Fu H. Zhang C, et al. Neural Regen Res. 2024 Oct 1;19(10):2132-2143. doi: 10.4103/1673-5374.392854. Epub 2024 Jan 8. Neural Regen Res. 2024. PMID: 38488548 Free PMC article. - Mechanisms of metabolic stress induced cell death of human oligodendrocytes: relevance for progressive multiple sclerosis.
Fernandes MGF, Mohammadnia A, Pernin F, Schmitz-Gielsdorf LE, Hodgins C, Cui QL, Yaqubi M, Blain M, Hall J, Dudley R, Srour M, Zandee SEJ, Klement W, Prat A, Stratton JA, Rodriguez M, Kuhlmann T, Moore W, Kennedy TE, Antel JP. Fernandes MGF, et al. Acta Neuropathol Commun. 2023 Jul 5;11(1):108. doi: 10.1186/s40478-023-01601-1. Acta Neuropathol Commun. 2023. PMID: 37408029 Free PMC article. - Toward Regulatory Effects of Curcumin on Transforming Growth Factor-Beta Across Different Diseases: A Review.
Ashrafizadeh M, Zarrabi A, Hushmandi K, Zarrin V, Moghadam ER, Hashemi F, Makvandi P, Samarghandian S, Khan H, Hashemi F, Najafi M, Mirzaei H. Ashrafizadeh M, et al. Front Pharmacol. 2020 Dec 14;11:585413. doi: 10.3389/fphar.2020.585413. eCollection 2020. Front Pharmacol. 2020. PMID: 33381035 Free PMC article. Review. - Continuous cuprizone intoxication allows active experimental autoimmune encephalomyelitis induction in C57BL/6 mice.
Yakimov V, Schweiger F, Zhan J, Behrangi N, Horn A, Schmitz C, Hochstrasser T, Kipp M. Yakimov V, et al. Histochem Cell Biol. 2019 Aug;152(2):119-131. doi: 10.1007/s00418-019-01786-4. Epub 2019 Apr 23. Histochem Cell Biol. 2019. PMID: 31016368
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous